Diagnostic Value of Serum Pancreatic Stone Protein in Gestational Diabetes Mellitus: A Prospective Cohort Study
Journal of Clinical Medicine · 02.04.2026 · 15 (7) · 2702
DOI: 10.3390/jcm15072702 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.04.2026. Verfasst von Murat Polat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, 06170 Ankara, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Pancreatic stone protein (PSP) is a secretory protein associated with systemic inflammation and β-cell stress. Given its reported association with type 2 diabetes mellitus, this study aimed to evaluate the relationship between serum PSP levels and gestational diabetes mellitus (GDM) and to assess its diagnostic performance.
Methods
This single-center, prospective cohort study was conducted between June 2024 and May 2025. Eighty-four pregnant women at 24–28 weeks’ gestation were enrolled: 42 diagnosed with GDM according to Carpenter–Coustan criteria and 42 healthy controls. Serum PSP levels were measured using ELISA at the time of GDM diagnosis, and prior to treatment initiation. Group comparisons were performed using appropriate parametric and non-parametric tests. Diagnostic performance was evaluated by receiver operating characteristic (ROC) curve analysis.
Results
Maternal weight was significantly higher in the GDM group (78.3 ± 10.0 kg vs. 68.4 ± 7.6 kg, p < 0.001). Serum PSP levels were significantly elevated in women with GDM compared to controls (8.89 ± 0.81 ng/mL vs. 7.72 ± 0.64 ng/mL, p < 0.001). Neonatal birth weight was also higher in the GDM group (3606 ± 507 g vs. 3355 ± 308 g, p = 0.008), while Apgar scores did not differ significantly. ROC analysis demonstrated an AUC of 0.883 (95% CI: 0.805–0.946, p < 0.001). At a cut-off value of 8.38 ng/mL, sensitivity was 76.2% and specificity was 85.7%.
Conclusions
Serum PSP levels are significantly elevated in GDM and demonstrate good diagnostic performance. PSP may serve as a supportive biomarker reflecting β-cell stress in GDM, warranting further multicenter validation studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, 06170 Ankara, Turkey.
- Department of Medical Biochemistry, Ankara Etlik City Hospital, 06170 Ankara, Turkey.
ORCID-Profile: Murat Polat, Sait Erbey, Mehmet Alican Sapmaz, Ömer Osman Eroğlu
Zitieren
APA
Polat, M., Erbey, S., Sapmaz, M. A., Eroğlu, Ö. O., & Şeker, R. (2026). Diagnostic Value of Serum Pancreatic Stone Protein in Gestational Diabetes Mellitus: A Prospective Cohort Study. Journal of Clinical Medicine, 15(7), 2702. https://doi.org/10.3390/jcm15072702
Vancouver
Polat M, Erbey S, Sapmaz MA, Eroğlu ÖO, Şeker R. Diagnostic Value of Serum Pancreatic Stone Protein in Gestational Diabetes Mellitus: A Prospective Cohort Study. Journal of Clinical Medicine. 2026;15(7):2702. doi:10.3390/jcm15072702
BibTeX
@article{Polat2026,
author = {Polat, Murat and Erbey, Sait and Sapmaz, Mehmet Alican and Eroğlu, Ömer Osman and Şeker, Rabia},
title = {Diagnostic Value of Serum Pancreatic Stone Protein in Gestational Diabetes Mellitus: A Prospective Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {7},
pages = {2702},
doi = {10.3390/jcm15072702}
}
EUVIMED